SLC36A1 (PAT1) is an electrogenic proton/amino acid symporter that mediates the transport of small apolar L-amino acids, their D-enantiomers, and amino acid derivatives including GABA and taurine 1. The transporter functions as a pH-dependent, sodium-independent carrier in intestinal epithelium 2, where it mediates bulk taurine absorption at physiologically relevant dietary concentrations and accepts diverse substrates including proline, glycine, beta-alanine, and delta-aminolevulinic acid 34. SLC36A1 is also localized to lysosomal membranes where it may facilitate amino acid efflux from lysosomes 5. Functionally, SLC36A1 regulates intestinal homeostasis through a microbiota-host feedback loop; the microbial metabolite 4-guanidinobutanoic acid upregulates SLC36A1 to enhance intestinal stem cell function and goblet cell differentiation via Hedgehog signaling activation, with reduced SLC36A1 expression correlating with ulcerative colitis severity 6. In cancer biology, SLC36A1 promotes therapeutic resistance through mTORC1 activation in melanoma treated with CDK4/6 inhibitors 7 and enhances glucose starvation tolerance in kidney cancer via TFE3-dependent transcriptional regulation 5. Additionally, elevated taurine transport via SLC36A1 may restrain inflammaging by inhibiting NLRP3 inflammasome activation 8.